Prognostic value of myocardial salvage index assessed by cardiovascular magnetic resonance in reperfused ST-segment elevation myocardial infarction

• Published in: Frontiers in cardiovascular medicine Vol. 9; p. 933733
• Main Authors: Zhang, Shiru, Ma, Quanmei, Jiao, Yundi, Wu, Jiake, Yu, Tongtong, Hou, Yang, Sun, Zhijun, Zheng, Liqiang, Sun, Zhaoqing
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 16-08-2022
• Subjects: cardiovascular magnetic resonance; Cardiovascular Medicine; major adverse cardiovascular event; myocardial salvage index; prognosis; ST-segment elevation myocardial infarction
• ISSN: 2297-055X; 2297-055X
• DOI: 10.3389/fcvm.2022.933733

Aims
Cardiovascular magnetic resonance (CMR) is a powerful tool to quantify the myocardial area at risk (AAR) and infarct size (IS), and evaluate the extent of myocardial salvage in acute ST-segment elevation myocardial infarction (STEMI). This study aimed to assess the prognostic value of myocardial salvage index (MSI) assessed by CMR in reperfused STEMI and investigate whether MSI could improve the predictive efficacy of the Global Registry of Acute Coronary Events (GRACE) risk score.
Methods and results:
About 104 consecutive patients who were hospitalized with first-time STEMI and received reperfusion therapy were prospectively enrolled. The primary endpoint was the incident of major adverse cardiovascular event (MACE) including all-cause mortality, non-fatal myocardial reinfarction and congestive heart failure within 36 months after the index event. Cox regression analysis was used to evaluate the prognostic association of MSI with MACE risk. About 21 (20.2%) patients developed MACE during the 3-year follow-up period, and patients with MSI < median had a higher incidence of MACE than those with MSI ≥ median [16 (30.8%) vs. 5 (9.6%),
P
= 0.007]. After adjusting all the parameters associated with MACE in univariate Cox analysis, MSI assessed by CMR remained independently significant as a predictor of MACE in multivariate Cox analysis (hazard ratio 0.963, 95% CI: 0.943–0.983;
P
< 0.001). Adding MSI to the GRACE risk score significantly increased the prognostic accuracy of the GRACE risk score (area under the curve: 0.833 vs. 0.773;
P
= 0.044), with a net reclassification improvement of 0.635 (
P
= 0.009) and an integrated discrimination improvement of 0.101 (
P
= 0.002).
Conclusion
This study confirmed that MSI assessed by CMR had a good long-term prognostic value in reperfused STEMI and improve the prognostic performance of the GRACE risk score.